University Of Virginia
Clinical trials sponsored by University Of Virginia, explained in plain language.
-
Sound waves and supercharged immune cells take on deadly brain tumors
Disease control Recruiting nowThis early-stage study tests a new treatment for a type of aggressive brain cancer called glioblastoma. The approach uses the patient's own immune cells, trained to attack the tumor, combined with low-intensity focused ultrasound to temporarily open the blood-brain barrier so the…
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control
Last updated May 01, 2026 16:34 UTC
-
Immune cell army targets Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis study tests a new treatment for people with advanced pancreatic cancer that cannot be removed by surgery. The treatment uses the patient's own immune cells, which are mixed with a special antibody to help them attack cancer cells. Participants receive 8 infusions twice a wee…
Phase: PHASE1, PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Artificial pancreas may protect hearts of type 1 diabetes patients
Disease control Recruiting nowThis study tests whether a closed-loop artificial pancreas system can improve blood sugar control and reduce heart disease risk in 40 adults with type 1 diabetes. Participants will use a continuous glucose monitor and insulin pump that work together automatically. The researchers…
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Urine test could personalize TB treatment, boost success
Disease control Recruiting nowThis study tests whether adjusting the dose of the TB drug rifampin based on a simple urine test can improve treatment outcomes. Researchers will enroll 200 adults and children with active, drug-sensitive tuberculosis in Tanzania. The goal is to see if personalized dosing helps m…
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug cocktail shows promise for Tough-to-Treat lymphoma
Disease control Recruiting nowThis study is for people with a rare type of blood cancer called peripheral T-cell lymphoma (PTCL) that has returned or not responded to prior therapy. It tests whether taking two drugs together (oral azacytidine and romidepsin) works better than taking one of several standard si…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New pill could help type 1 diabetes patients use less insulin
Disease control Recruiting nowThis study tests an experimental drug called CIR-0602K in 40 adults with type 1 diabetes who already use an automated insulin pump. The goal is to see if the drug helps keep blood sugar in a healthy range longer and reduces the amount of insulin needed each day. Participants will…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Can a simple antibiotic fix stunted growth in poor children?
Disease control Recruiting nowThis study tests different antibiotics to treat small intestine bacterial overgrowth (SIBO) in 60 malnourished children in Bangladesh. The goal is to find the best treatment to help children grow normally and avoid stunting. Participants must have a positive breath test for SIBO …
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Can a patch beat a pill? new study tests estrogen for stronger bones
Disease control Recruiting nowThis study looks at whether natural estrogen given through a skin patch improves bone strength better than natural estrogen pills or a synthetic birth control patch in women aged 14-30 with functional hypothalamic amenorrhea (missing periods). Participants take estrogen for one y…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Rural smokers get help quitting through local pharmacies
Disease control Recruiting nowThis study tests whether a pharmacist-led coaching program called QuitAid helps rural smokers in Appalachia quit cigarettes. About 768 participants will receive nicotine patches and may also get text support, phone counseling, or extra nicotine gum. The goal is to find the best c…
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New immune cell therapy targets hidden leukemia cells
Disease control Recruiting nowThis early-phase study tests a new treatment for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who still have small amounts of cancer cells after standard therapy. The treatment uses the patient's own blood cells that are specially prepared in the lab…
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Blood test may allow safer, Lower-Dose radiation for head and neck cancer
Disease control Recruiting nowThis study tests whether a blood test that tracks HPV DNA can help doctors safely give a lower dose of radiation to the neck in people with head and neck cancer. About 90 adults with oropharynx cancer will receive radiation tailored to their blood test results. The goal is to see…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New clotting drug may stop bleeding in Heart-Lung machine patients
Disease control Recruiting nowThis early-stage study tests a single dose of a lab-made clotting protein (recombinant von Willebrand factor) in 12 adults on ECMO who have severe bleeding. The goal is to see if the drug is safe and how it works in the body. ECMO patients often bleed because their natural clotti…
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Ketamine combo may halt stubborn seizures in ER
Disease control Recruiting nowThis study tests whether adding two doses of ketamine to the usual seizure medicine (levetiracetam) stops prolonged seizures (status epilepticus) more effectively than the medicine alone. About 770 people aged 1 year and older who are still seizing after first-line treatment will…
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
App aims to ease anxiety in movement disorders
Symptom relief Recruiting nowThis study tests a mobile app designed to help people with Parkinson's or Huntington's disease feel less anxious. The app works by training users to interpret everyday situations in a less threatening way. Researchers will enroll 136 adults with anxiety symptoms to see if the app…
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
Magic mushroom therapy targets deep grief in small trial
Symptom relief Recruiting nowThis early-phase study tests whether psilocybin-assisted therapy is feasible for people with prolonged grief disorder. Twelve adults aged 18-65 with severe grief symptoms will receive the treatment and be followed for 6 months. The main goals are to see if people join and stay in…
Phase: EARLY_PHASE1 • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Apr 30, 2026 15:49 UTC
-
New study tests meditation as a pain reliever for back pain sufferers who Can't sleep
Symptom relief Recruiting nowThis study looks at whether adding a meditation program or pain education to standard sleep therapy can help reduce pain intensity in adults with chronic low back pain and insomnia. About 300 participants will receive cognitive behavioral therapy for insomnia, then be assigned to…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Apr 29, 2026 15:15 UTC
-
Sound waves target cancer pain without surgery
Symptom relief Recruiting nowThis early-stage study tests a new way to treat severe pain from head, neck, and brachial cancers when opioids no longer help. Using MRI-guided focused ultrasound, doctors create a small lesion in the brain's pain pathway to block pain signals. The study involves 20 adults aged 1…
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Apr 29, 2026 15:01 UTC
-
Vaginal infections may worsen surgical wounds, new study investigates
Knowledge-focused Recruiting nowThis study looks at whether common vaginal infections (like yeast or bacterial vaginosis) increase the risk of wound problems after vulvar surgery for non-cancerous growths. About 91 adults will be tested with a simple swab before surgery, then checked one week and 4-6 weeks afte…
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated May 01, 2026 16:01 UTC
-
Scientists investigate surprising link between mouth germs and exercise ability
Knowledge-focused Recruiting nowThis study looks at how fitness level relates to bacteria in the mouth and blood flow to muscles. Researchers will collect mouth swabs, saliva, and blood samples, and measure exercise capacity on a bike. The goal is to understand these connections in people with heart failure, ar…
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Diabetes drug may limit your workout, study suggests
Knowledge-focused Recruiting nowThis study looks at whether metformin, a drug used to lower blood sugar in people with type 2 diabetes, changes how well healthy young adults can exercise. Twenty people aged 18-30 will take metformin or a placebo and do several bike tests. The goal is to see if metformin reduces…
Phase: PHASE4 • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC
-
Hormone therapy before surgery may help some women skip radiation
Knowledge-focused Recruiting nowThis study is for women aged 65 and older with early-stage, hormone-sensitive breast cancer. It tests whether taking hormone pills for 3 months before surgery helps patients and their doctors make a more informed decision about whether to skip radiation after surgery. Half the pa…
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC
-
Chatbot vs. counselor: which helps more people get cancer genetic testing?
Knowledge-focused Recruiting nowThis study looks at two ways to provide genetic counseling before cancer genetic testing: with a human genetic counselor or with a chatbot called GIA. The goal is to see if the chatbot can help more people in rural areas decide to get tested. Participants will answer questions, p…
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC